EVH vs ALHC vs CNC vs MOH

For growth investors, Alignment Healthcare, Inc.

(ALHC) is the stronger pick with 46. 1% revenue growth year-over-year, versus -26. 6% for Evolent Health, Inc. (EVH). Molina Healthcare, Inc. (MOH) offers the better valuation at 21. 5x trailing P/E (37. 2x forward), making it the more compelling value choice. Analysts rate Evolent Health, Inc. (EVH) a "Buy" — based on 29 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

On forward P/E, Centene Corporation is actually cheaper at 16.

3x — notably different from the trailing picture, reflecting expected earnings growth.

Over the past 5 years, Centene Corporation (CNC) delivered a total return of -22.

0%, compared to -78. 4% for Evolent Health, Inc. (EVH). Over 10 years, the gap is even starker: MOH returned +306. 6% versus EVH's -63. 6%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), Molina Healthcare, Inc.

(MOH) is the lower-risk stock at -0. 04β versus Evolent Health, Inc. 's 1. 21β — meaning EVH is approximately -3403% more volatile than MOH relative to the S&P 500. On balance sheet safety, Centene Corporation (CNC) carries a lower debt/equity ratio of 94% versus 2% for Evolent Health, Inc. — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), Alignment Healthcare, Inc.

(ALHC) is pulling ahead at 46. 1% versus -26. 6% for Evolent Health, Inc. (EVH). On earnings-per-share growth, the picture is similar: Alignment Healthcare, Inc. grew EPS 99. 4% year-over-year, compared to -525. 9% for Evolent Health, Inc.. Over a 3-year CAGR, ALHC leads at 40. 2% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

Molina Healthcare, Inc.

(MOH) is the more profitable company, earning 1. 0% net margin versus -28. 5% for Evolent Health, Inc. — meaning it keeps 1. 0% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: MOH leads at 1. 7% versus -3. 9% for CNC. At the gross margin level — before operating expenses — EVH leads at 15. 1%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

On forward earnings alone, Centene Corporation (CNC) trades at 16.

3x forward P/E versus 140. 9x for Alignment Healthcare, Inc. — 124. 6x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for EVH: 49. 1% to $6. 38.

In this comparison, EVH (2.

3% yield) pays a dividend. ALHC, CNC, MOH do not pay a meaningful dividend and should not be held primarily for income.

For long-horizon retirement investors, Molina Healthcare, Inc.

(MOH) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β -0. 04), +306. 6% 10Y return). Both have compounded well over 10 years (MOH: +306. 6%, ALHC: +5. 4%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

In terms of investment character: EVH is a small-cap quality compounder stock; ALHC is a small-cap high-growth stock; CNC is a mid-cap high-growth stock; MOH is a small-cap quality compounder stock. EVH pays a dividend while ALHC, CNC, MOH do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.